The Clorox Company (NYSE:CLX) to Post Q4 2024 Earnings of $1.41 Per Share, DA Davidson Forecasts

The Clorox Company (NYSE:CLX) – Stock analysts at DA Davidson issued their Q4 2024 earnings per share estimates for Clorox in a research report issued to clients and investors on Wednesday, May 1st. DA Davidson analyst L. Weiser expects that the company will post earnings per share of $1.41 for the quarter. DA Davidson has a “Neutral” rating and a $162.00 price target on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.52 per share. DA Davidson also issued estimates for Clorox’s FY2025 earnings at $6.03 EPS.

Several other equities analysts have also recently weighed in on the company. Citigroup cut their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating on the stock in a report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Barclays cut their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 10th. Evercore ISI cut their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a research note on Wednesday. Finally, Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $149.38.

Clorox Price Performance

Clorox stock opened at $139.64 on Thursday. Clorox has a 1 year low of $114.68 and a 1 year high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The firm has a market capitalization of $17.33 billion, a P/E ratio of 72.35, a PEG ratio of 2.34 and a beta of 0.44. The business has a 50-day moving average of $149.00 and a 200-day moving average of $143.10.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a return on equity of 305.36% and a net margin of 3.33%. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.51 EPS.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.44%. Clorox’s payout ratio is 248.71%.

Institutional Trading of Clorox

Institutional investors have recently modified their holdings of the stock. Point72 Asset Management L.P. bought a new stake in shares of Clorox during the 4th quarter worth $144,844,000. Norges Bank bought a new stake in shares of Clorox during the 4th quarter worth $128,382,000. Parsifal Capital Management LP bought a new stake in shares of Clorox during the 4th quarter worth $128,245,000. Confluence Investment Management LLC bought a new stake in shares of Clorox during the 1st quarter worth $135,630,000. Finally, Qube Research & Technologies Ltd lifted its position in shares of Clorox by 75.9% during the 3rd quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after buying an additional 487,974 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.